BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36265733)

  • 1. Recent advances in flavonoid-based nanocarriers as an emerging drug delivery approach for cancer chemotherapy.
    Dewanjee S; Chakraborty P; Bhattacharya H; Singh SK; Dua K; Dey A; Jha NK
    Drug Discov Today; 2023 Jan; 28(1):103409. PubMed ID: 36265733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional Nanoparticles in Precise Cancer Treatment: Considerations in Design and Functionalization of Nanocarriers.
    Lu L; Kang S; Sun C; Sun C; Guo Z; Li J; Zhang T; Luo X; Liu B
    Curr Top Med Chem; 2020; 20(27):2427-2441. PubMed ID: 32842941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavonoid Nanoparticles: A Promising Approach for Cancer Therapy.
    Dobrzynska M; Napierala M; Florek E
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32887473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects.
    Khan H; Ullah H; Martorell M; Valdes SE; Belwal T; Tejada S; Sureda A; Kamal MA
    Semin Cancer Biol; 2021 Feb; 69():200-211. PubMed ID: 31374244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarrier-based Drug Delivery System for Cancer Therapeutics: A Review of the Last Decade.
    Sohail M; Guo W; Li Z; Xu H; Zhao F; Chen D; Fu F
    Curr Med Chem; 2021; 28(19):3753-3772. PubMed ID: 33019919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
    Gupta A; Kushwaha SS; Mishra A
    Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Targeted Drug Delivery Approaches Using Lipidic and Polymeric Nanocarriers for the Management of Alzheimer's Disease.
    Jain D; Rashid MA; Ahmad FJ
    Curr Pharm Des; 2021; 27(43):4388-4403. PubMed ID: 34579627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy.
    Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A
    Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-responsive smart nanocarriers for targeted chemotherapy: an overview.
    Kapalatiya H; Madav Y; Tambe VS; Wairkar S
    Drug Deliv Transl Res; 2022 Jun; 12(6):1293-1305. PubMed ID: 34251612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral bioavailability: issues and solutions via nanoformulations.
    Pathak K; Raghuvanshi S
    Clin Pharmacokinet; 2015 Apr; 54(4):325-57. PubMed ID: 25666353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology Assisted Chemotherapy for Targeted Cancer Treatment: Recent Advances and Clinical Perspectives.
    Lan HR; Wu ZQ; Zhang LH; Jin KT; Wang SB
    Curr Top Med Chem; 2020; 20(27):2442-2458. PubMed ID: 32703133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances and prospects in gemcitabine drug delivery systems.
    Paroha S; Verma J; Dubey RD; Dewangan RP; Molugulu N; Bapat RA; Sahoo PK; Kesharwani P
    Int J Pharm; 2021 Jan; 592():120043. PubMed ID: 33152476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular insights and therapeutic implications of nanoengineered dietary polyphenols for targeting lung cancer: part II.
    Das SS; Tambe S; Prasad Verma PR; Amin P; Singh N; Singh SK; Gupta PK
    Nanomedicine (Lond); 2022 Oct; 17(23):1799-1816. PubMed ID: 36636965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial Benefits of Flavonoids and their Nanoformulations.
    Salatin S; Bazmani A; Shahi S; Naghili B; Memar MY; Dizaj SM
    Curr Pharm Des; 2022; 28(17):1419-1432. PubMed ID: 35579158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in Delivery of Chemotherapeutic Agents for Cancer Treatment.
    Yadav A; Singh S; Sohi H; Dang S
    AAPS PharmSciTech; 2021 Dec; 23(1):25. PubMed ID: 34907501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimuli-responsive Polymeric Nanosystems for Therapeutic Applications.
    Handa M; Singh A; Flora SJS; Shukla R
    Curr Pharm Des; 2022; 28(11):910-921. PubMed ID: 34879797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in dual-ligand targeted nanocarriers for cancer therapy.
    Khan N; Ruchika ; Dhritlahre RK; Saneja A
    Drug Discov Today; 2022 Aug; 27(8):2288-2299. PubMed ID: 35439614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug nanocarriers and functional nanoparticles: applications in cancer therapy.
    Thierry B
    Curr Drug Deliv; 2009 Aug; 6(4):391-403. PubMed ID: 19534706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.